Cutler Group LLC / CA - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 55 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2017$0
-100.0%
300
-99.8%
0.00%
-100.0%
Q1 2017$46,000
+1433.3%
145,684
+3381.9%
0.00%
Q4 2016$3,000
-72.7%
4,184
-81.7%
0.00%
Q3 2016$11,00022,884
+27142.9%
0.00%
Q2 2016$0840.0%0.00%
Q1 2016$0
-100.0%
84
-95.0%
0.00%
Q4 2015$6,0001,6680.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$15,687,0002.68%
Northeast Financial Consultants Inc 732,265$3,105,0001.31%
WEDBUSH SECURITIES INC 15,000$64,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$628,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,752,0000.01%
Virtu KCG Holdings LLC 72,989$309,0000.01%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,555$151,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$64,0000.00%
BlackRock Fund Advisors 612,231$2,596,0000.00%
Spot Trading L.L.C 15,000$64,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders